Tradestie Institutional Equity Comparison Engine

IMMX vs VIVS โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-19 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

IMMX Overall Edge

IMMX Captures Institutional Edge (3โ€“0 Pillars ยท 7โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Immix Biopharma, Inc. Common Stock (IMMX) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, IMMX trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus VIVS at N/M Forward P/E and -10117.0% operating margin (-51.4% YoY). In options structure, IMMX sits in BREAKDOWN (22nd %ile IV; Dealer Gamma Walls on Pro) against VIVS sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
IMMX N/M vs VIVS N/M Fwd P/E
Growth & Margin Winner IMMX
Op Margin 0.0% vs -10117.0% ยท YoY +0.0% vs -51.4%
Momentum & Technical Winner IMMX
1Y +65.7% vs -87.0% ยท 52W Pos 29% vs 5%
Options & Structure Winner IMMX
BREAKDOWN (22nd %ile IV) vs BREAKDOWN (N/A IV)
IMMX NASDAQ
Immix Biopharma, Inc. Common Stock
Pharmaceutical Preparations
$7.04
-0.98% 1D
Market Cap $602.6M
1M Return -17.27%
1Y Return +65.65%
Forward P/E N/M
Unified AI Score
57.3 / 100 HOLD
Tech 61.0 Fund 63.0 Flow 69.0 Mom 64.0
VIVS NASDAQ
VivoSim Labs, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$0.29
+142.92% 1D
Market Cap $2.4M
1M Return +64.69%
1Y Return -86.99%
Forward P/E N/M
Unified AI Score
36.8 / 100 SELL
Tech 5.0 Fund 38.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: IMMX +65.65% VIVS -86.99% Spread: +152.64 pp (IMMX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
IMMX TTM Op. Margin: 0.0% VIVS TTM Op. Margin: -10117.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on IMMX vs VIVS. Trailing 12-month operating profitability (IMMX 0.0% vs VIVS -10117.0%) and valuation multiples (IMMX N/M vs VIVS N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: IMMX (7) vs VIVS (0)
Institutional Metric IMMX VIVS Criterion Row Winner
Market Capitalization Scale $602.6M $2.4M Larger Scale IMMX
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% -51.4% Higher Growth IMMX
Operating Margin (TTM) Profitability 0.0% -10117.0% Higher Margin IMMX
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -27.0% -343.1% Higher ROE IMMX
52-Week Range Position Momentum 29% ($4โ€“$15) 5% ($0โ€“$3) Stronger Trend IMMX
Beta / 30D Volatility Risk Regime 1.80ฮฒ ยท 76% Vol 0.83ฮฒ ยท 480% Vol Lower Realized Risk IMMX
Unified Institutional Score Composite Signal 57.3 / 100 (HOLD) 36.8 / 100 (SELL) Higher Composite IMMX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full IMMX vs VIVS Buy Guide
IMMX BREAKDOWN
61d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 22nd %ile
IV Regime Compressed (<25th %ile)
Live IMMX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
VIVS BREAKDOWN
73d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live VIVS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither IMMX nor VIVS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.